Adhesive cell tissue gels

US12186397B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12186397-B2
Application numberUS-201816173769-A
CountryUS
Kind codeB2
Filing dateOct 29, 2018
Priority dateJun 23, 2011
Publication dateJan 7, 2025
Grant dateJan 7, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A cell tissue gel, comprising one or more matrix molecules cross-linked with a cross-linking agent, and a quenching agent bound to a reactive group of the cross-linking agent, wherein the quenching agent contains a moiety that is capable of reacting with the reactive group of the cross-linking agent and the one or more matrix molecules contain one or more functional groups that are capable of cross-linking with the reactive group, the amount of the reactive group of the cross-linking agent being equal to or less than a total amount including the amount of the one or more functional groups and the amount of the moiety.

First claim

Opening claim text (preview).

What is claimed is: 1. A cell tissue gel, comprising one or more matrix molecules cross-linked with a cross-linking agent, and a quenching agent bound to a reactive group of the cross-linking agent, wherein the quenching agent contains a moiety that is capable of reacting with the reactive group of the cross-linking agent and the one or more matrix molecules contain one or more functional groups that are capable of cross-linking with the reactive group, the moiety being in an amount sufficient to react with any reactive group not cross-linked to the one or more functional groups and to reduce the cytotoxicity of the cell tissue gel cross-linked with the cross-linking agent, wherein the quenching agent is a polyglutamic acid and the cross-linking agent is not glutaraldehyde or N-hydroxysuccinimide ester, wherein the cell tissue gel lacks any fibroblast growth factor, and wherein the cytotoxicity of the cell tissue gel is reduced as compared to in the absence of the quenching agent. 2. The cell tissue gel of claim 1 , wherein the cross-linking agent is selected from the group consisting of an epoxide, and genipin. 3. The cell tissue gel of claim 1 , wherein the one or more matrix molecules are selected from the group consisting of collagen, hyaluronan, gelatin, fibronectin, elastin, tenacin, laminin, vitronectin, heparan sulfate, chondroitin, chondroitin sulfate, keratan, keratan sulfate, dermatan sulfate, carrageenan, heparin, chitin, chitosan, alginate, agarose, agar, cellulose, methyl cellulose, carboxyl methyl cellulose, and glycogen. 4. The cell tissue of claim 3 , wherein the one or more matrix molecules are selected from the group consisting of collagen, hyaluronan, and gelatin. 5. The cell tissue gel of claim 1 , further comprising a nutrient, a bioactive agent, or both. 6. The cell tissue gel of claim 5 , wherein the nutrient is a cell culture medium. 7. The cell tissue gel of claim 5 , wherein the bioactive agent is a growth factor selected from the group consisting of epidermal growth factor, vascular endothelial growth factor, connective tissue growth factor, platelet-derived growth factor, insulin-like growth factor, nerve growth factor, hepatocyte growth factor, colony-stimulating factor, stem cell factor, keratinocyte growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, glial derived neurotrophic factor, ciliary neurotrophic factor, endothelial-monocyte activating polypeptide, epithelial neutrophil activating peptide, erythropoietin, bone morphogenetic protein, brain-derived neurotrophic factor, BRAK, transforming growth factor beta, and tumor necrosis factor. 8. The cell tissue gel of claim 1 , further comprising cells. 9. The cell tissue gel of claim 2 , wherein the cross-linking agent is an epoxide. 10. The cell tissue gel of claim 9 , wherein the one or more matrix molecules are selected from the group consisting of collagen, hyaluronan, and gelatin. 11. The cell tissue gel of claim 9 , wherein the quenching agent is γ-polyglutamic acid and the one or more matrix molecules are selected from the group consisting of collagen, hyaluronan, and gelatin. 12. The cell tissue gel of claim 1 , wherein the cell tissue gel lacks any growth factor. 13. The cell tissue gel of claim 1 , wherein the one or more matrix molecules do not include a synthetic polymer or an acrylate.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12186397B2 cover?
A cell tissue gel, comprising one or more matrix molecules cross-linked with a cross-linking agent, and a quenching agent bound to a reactive group of the cross-linking agent, wherein the quenching agent contains a moiety that is capable of reacting with the reactive group of the cross-linking agent and the one or more matrix molecules contain one or more functional groups that are capable of c…
Who is the assignee on this patent?
Univ Nat Cheng Kung
What technology area does this patent fall under?
Primary CPC classification A61K47/34. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).